nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
|
Rinciog, C. |
|
2016 |
35 |
4 |
p. 479-491 |
artikel |
2 |
Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
|
Kearns, Benjamin |
|
2016 |
35 |
4 |
p. 415-424 |
artikel |
3 |
Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
|
Fust, Kelly |
|
2016 |
35 |
4 |
p. 425-438 |
artikel |
4 |
Economic Studies in Motor Neurone Disease: A Systematic Methodological Review
|
Moore, Alan |
|
2016 |
35 |
4 |
p. 397-413 |
artikel |
5 |
Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?
|
Mulhern, Brendan |
|
2016 |
35 |
4 |
p. 439-451 |
artikel |
6 |
Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15
|
Mpundu-Kaambwa, Christine |
|
2016 |
35 |
4 |
p. 453-467 |
artikel |
7 |
Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US
|
Hoefman, Renske J. |
|
2016 |
35 |
4 |
p. 469-478 |
artikel |